GTM-WKRD365
Skip to main content
  1. Home >
  2. Sobre a Fujitsu>
  3. Digital Annealer speeds up Polarisqb’s drug discovery platform 10,000 times faster than traditional molecular analysis

Digital Annealer speeds up Polarisqb’s drug discovery platform 10,000 times faster than traditional molecular analysis

"Our expertise in chemistry and machine-learning, combined with Fujitsu’s technology and experience, means we can identify viable molecules quickly."

Shahar Keinan, CEO & Founder, Polarisqb

Accelerating drug discovery through collaboration

Customer

Polarisqb is a Research Triangle Park-based start-up which aims to transform global health through the rapid creation of drug blueprints for all human proteins, disease pathways, genetic mutations, and pathogens. The company combines the powers of quantum computing, AI, and precision medicine to research chemical space in order to create novel molecular drugs for specific proteins and diseases.

Challenge

To accelerate the drug discovery process to fight diseases using quantum-inspired computing, machine-learning and QM/MM.

Solution

A platform combining Fujitsu’s Digital Annealer with Polarisqb’s chemistry and machine-learning algorithms to speed up drug discovery

Download

CS_2020Sep_Polarisqb (389 KB)